[Muscular toxicity from clofibrate treatment in hypopituitarism: role of SIADH].
Schneider
S
S
Service de Médecine Interne I, Hôpital de Cimiez, Nice.
Heudier
P
P
Taillan
B
B
Chichmanian
R M
RM
Dujardin
P
P
D000368:Aged; D002994:Clofibrate / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000188:drug therapy*; D007018:Hypopituitarism / Q000150:complications*; D007177:Inappropriate ADH Syndrome / Q000209:etiology*; D012206:Rhabdomyolysis / Q000139:chemically induced*
D002994:Clofibrate
Toxicité musculaire d'un traitement par fibrates au cours d'un hypopituitarisme: rôle d'un SIADH.